Loading…
Artelo Biosciences, Inc. is projected to rise to $1.67 by 2027, a +23% move from its current price of $1.36. ARTL is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $1.22 | $1.36 | $1.52 | -0.02% |
| May 30 | $1.17 | $1.36 | $1.58 | -0.05% |
| May 31 | $1.13 | $1.36 | $1.64 | -0.07% |
| Jun 1 | $1.09 | $1.36 | $1.69 | -0.10% |
| Jun 2 | $1.07 | $1.36 | $1.73 | -0.12% |
| Jun 3 | $1.04 | $1.36 | $1.77 | -0.15% |
| Jun 4 | $1.02 | $1.36 | $1.81 | -0.17% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $1.02 | $1.36 | $1.81 | -0.17% |
| Week 2 | $0.9036 | $1.36 | $2.03 | -0.34% |
| Week 3 | $0.8235 | $1.35 | $2.22 | -0.51% |
| Week 4 | $0.7613 | $1.35 | $2.40 | -0.68% |
| Week 5 | $0.7102 | $1.35 | $2.56 | -0.85% |
| Week 6 | $0.667 | $1.35 | $2.72 | -1.02% |
| Week 7 | $0.6294 | $1.34 | $2.87 | -1.19% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Artelo Biosciences, Inc. is a clinical stage biopharmaceutical company that develops therapeutics targeting lipid-signaling pathways in the United States. Its product candidate pipeline includes ART27.13, a synthetic dual cannabinoid G protein-coupled receptor agonist, which is in Phase 1b/2a clinical trial for the treatment of cancer-related anorexia; ART12.11, a cocrystal composition of cannabidiol and tetramethylpyrazine for the treatment anxiety, depression, PTSD, epilepsy and insomnia, and other potential indications; and ART26.12, a fatty acid binding protein 5 inhibitor for treating chemotherapy induced peripheral neuropathy, diabetic neuropathy, prostate cancer and breast cancer, pain, dermatologic conditions, and anxiety disorders.
The company was formerly known as Reactive Medical Inc. and changed its name to Artelo Biosciences, Inc. in April 2017. Artelo Biosciences, Inc. was incorporated in 2011 and is based in Solana Beach, California.
Artelo Biosciences, Inc. trades under the symbol ARTL. The current price is $1.36 and the market capitalization is $3.17M, with a rank of 5355. The company operates in the Healthcare sector.
The price outlook is reflected in the year-by-year forecast, which shows a bullish trajectory beyond 2026 with higher average prices and notable gains in later years, including 2040 and 2050.
A major floor 12.5% below — a decisive break under it would weaken the trend.
The nearest floor, 12.5% below — buyers have tended to step in here.
The nearest ceiling, 290.4% above — a clean break opens room to run.
A major ceiling 675.0% above — clearing it would confirm fresh momentum.
Key ARTL support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of ARTL market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $1.40 | Sell | $1.47 | Sell |
| MA 10 | $1.63 | Sell | $1.70 | Sell |
| MA 20 | $2.29 | Sell | $2.31 | Sell |
| MA 50 | $4.46 | Sell | $3.51 | Sell |
| MA 100 | $4.36 | Sell | $5.00 | Sell |
| MA 200 | $8.57 | Sell | $8.58 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 30.95 | Neutral |
| Stoch RSI (14) | 70.78 | Neutral |
| CCI (20) | -93.23 | Neutral |
| Williams %R (14) | -88.59 | Info |
| MACD (12,26,9) | 0.01 | Buy |
| ROC (12) | -46.46 | Sell |
| Bollinger %B (20,2) | 0.20 | Neutral |
| Stochastic %K (14) | 11.41 | Buy |
| TRIX (15) | -3.25 | Sell |
| Awesome (5,34) | -1.89 | Sell |
| Ultimate (7,14,28) | 29.09 | Buy |
| Momentum (10) | -1.04 | Sell |
| Aroon Osc (25) | -92.00 | Sell |
| Hull MA (9) | 1.35 | Buy |
| ADX (14) | 35.36 | Sell |
| ATR (14) | 0.27 | Info |
The 30-day technical picture is NEUTRAL. RSI14 is 30, SMA50 is $4.46, and SMA200 is $8.57. The 30-day range runs from $0.6657 to $2.78, with support at $1.19 and resistance at $5.31. The annualized volatility is 200%.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $1.19 | $1.36 | $2.04 | 0% | Neutral | |
| $1.20 | $1.67 | $2.51 | +23% | Bullish | |
| $1.51 | $2.22 | $3.55 | +63% | Bullish | |
| $1.33 | $2.07 | $3.47 | +52% | Bullish | |
| $1.06 | $1.73 | $3.01 | +27% | Bullish | |
| $1.15 | $1.95 | $3.51 | +43% | Bullish | |
| $0.9458 | $1.68 | $3.12 | +23% | Bullish | |
| $0.8981 | $1.66 | $3.17 | +22% | Bullish | |
| $1.27 | $2.44 | $4.77 | +79% | Bullish | |
| $1.35 | $2.69 | $5.39 | +98% | Bullish | |
| $1.18 | $2.61 | $5.75 | +92% | Bullish | |
| $2.45 | $5.43 | $12.50 | +300% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $1.19 | $1.36 | $1.60 | +0.00% |
| June 2026 | $1.06 | $1.27 | $1.58 | -6.43% |
| July 2026 | $1.09 | $1.33 | $1.70 | +4.52% |
| August 2026 | $1.14 | $1.40 | $1.82 | +5.55% |
| September 2026 | $1.05 | $1.32 | $1.74 | -6.14% |
| October 2026 | $1.01 | $1.28 | $1.71 | -2.94% |
| November 2026 | $1.11 | $1.41 | $1.91 | +10.51% |
| December 2026 | $1.16 | $1.49 | $2.04 | +5.23% |
Click any year to see its month-by-month ARTL forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
By 2026, ARTL could reach as high as $2.04, with a base case around $1.36 and support toward $1.19 — roughly 0% from $1.36. Price action looks broadly range-bound.
Expect ARTL to range from $1.20 to $2.51 through 2027. The $1.67 average target implies a +23% move from current prices. That is up +23% on the projected 2026 average. Buyers look set to stay in control over this stretch.
The ARTL price prediction for 2028 points to an average of $2.22 (low $1.51, high $3.55) — a potential gain of +63% on today's $1.36. Momentum favours further upside here.
In 2029, ARTL is projected to trade between $1.33 and $3.47, averaging $2.07 — a potential gain of +52% from today's $1.36. That is -7% versus the projected 2028 average. Buyers look set to stay in control over this stretch.
Artelo Biosciences, Inc.'s 2030 outlook centres on $1.73, within a $1.06 to $3.01 range. That is -17% versus the projected 2029 average. That marks a +27% change versus current levels. Momentum favours further upside here.
By 2031, ARTL could reach as high as $3.51, with a base case around $1.95 and support toward $1.15 — roughly +43% from $1.36. Buyers look set to stay in control over this stretch.
Expect ARTL to range from $0.9458 to $3.12 through 2032. The $1.68 average target implies a +23% move from current prices. That is -14% versus the projected 2031 average. Momentum favours further upside here.
The ARTL price prediction for 2033 points to an average of $1.66 (low $0.8981, high $3.17) — a potential gain of +22% on today's $1.36. Buyers look set to stay in control over this stretch.
In 2034, ARTL is projected to trade between $1.27 and $4.77, averaging $2.44 — a potential gain of +79% from today's $1.36. That is up +47% on the projected 2033 average. Momentum favours further upside here.
Artelo Biosciences, Inc.'s 2035 outlook centres on $2.69, within a $1.35 to $5.39 range. That is up +10% on the projected 2034 average. That marks a +98% change versus current levels. Buyers look set to stay in control over this stretch.
By 2040, ARTL could reach as high as $5.75, with a base case around $2.61 and support toward $1.18 — roughly +92% from $1.36. Momentum favours further upside here.
Expect ARTL to range from $2.45 to $12.50 through 2050. The $5.43 average target implies a +300% move from current prices. That is up +108% on the projected 2040 average. Buyers look set to stay in control over this stretch.
Investing $1,000 in ARTL today (≈ 735.294118 ARTL) could be worth
$3,995.3
+$2,995.3 (+300%) by 2050 · US Dollar
Based on the average projected ARTL price of $5.43 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in ARTLwould be worth at today's price.
$1,000 invested in ARTL on May 27, 2025 (≈ 57.273772 ARTL) would be worth
$77.89
-$922.11 (-92.2%) today · 0.08× · US Dollar
Based on a ARTL entry price of $17.46 vs. today's $1.36.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $1.42 | $957.75 | -4.2% |
| 1 month ago | $3.77 | $360.74 | -63.9% |
| 3 months ago | $3.72 | $365.59 | -63.4% |
| 6 months ago | $5.22 | $260.54 | -73.9% |
| 1 year ago | $17.46 | $77.89 | -92.2% |
| All time (5.0y) ago | $332.1 | $4.1 | -99.6% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our ARTL forecast.
Our base-case forecast reaches $2.70 around 2050.
Implied market cap at $2.70: $6.3M
The year-by-year forecast shows a progression toward higher averages and positive ROI over time. In 2026 the avg is $1.36 with 0% ROI and NEUTRAL sentiment; 2027 the avg is $1.67 with 23% ROI and BULLISH sentiment; 2028 the avg is $2.22 with 63.2% ROI and BULLISH sentiment; 2029 the avg is $2.07 with 52.1% ROI and BULLISH sentiment; 2030 the avg is $1.73 with 26.9% ROI and BULLISH sentiment. The forecast then extends with 2031 avg $1.95 ROI 43.3% BULLISH, 2032 avg $1.68 ROI 23.3% BULLISH, 2033 avg $1.66 ROI 21.9% BULLISH, 2034 avg $2.44 ROI 79.3% BULLISH, and 2035 avg $2.69 ROI 98% BULLISH.
Looking further ahead, 2040 shows avg $2.61 ROI 92.1% BULLISH and 2050 shows avg $5.43 ROI 299.5% BULLISH. These are estimates and not guarantees. The forecast indicates a bullish long-term path with meaningful upside by 2040 and 2050, but actual results may vary.
Tap a question to reveal the answer.
The forecast shows an average price of $1.73, a min of $1.06, a max of $3.01, with a 26.9% ROI and bullish sentiment.
The forecast shows bullish sentiment from 2027 onward, with rising averages and ROI, though 2026 is neutral with 0% ROI.
Yes, the 2050 forecast shows an average price of $5.43 and a max of $12.50, indicating upside potential by 2050.
Current price is $1.36 and market capitalization is $3.17M.
RSI14 is 30; SMA50 is $4.46; SMA200 is $8.57; the 30-day range is $0.6657 to $2.78, with support at $1.19 and resistance at $5.31; sentiment is NEUTRAL.
Artelo Biosciences, Inc. Community Discussion
0Share your Artelo Biosciences, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.